Navigation

Prof. Maree Hackett

Reader in Epidemiology

School of Health Sciences

Mhackett1@uclan.ac.uk

Maree is a Reader in Epidemiology at UCLAN and she leads a program of research at The George Institute for Global Health in Sydney, Australia, focusing on developing simple, cost effective strategies to prevent depression and significantly improve the outcome for people with cardiovascular disease. She has a particular interest in Aboriginal and Torres Strait Islander health. This is in concordance with her current National Heart Foundation Future Leader Fellowship (Level 2) on Improving the identification and management of depression in people with cardiovascular disease.

Full Profile

  • Ph.D. Medicine, University of Auckland, New Zealand, 2006
  • M.A. (Hons), Psychology, University of Auckland, New Zealand, 1994
  • B.A., Psychology and English, University of Auckland, New Zealand, 1992

RESEARCH INTERESTS:

Psychological problems in people with physical illness

  • Stroke
  • Cardiovascular disease
  • Epilepsy
  • Depression
  • Quality of life

Teaching Activities and Responsibilities

University of Sydney: MIPH 5127 Mental disorders in a global context.


Publications

Hackett ML, Pickles K. Part I: Frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. International Journal of Stroke 2014;9:1017-1025

Kutlabaev MA, Hackett ML. Part II: Predictors of depression after stroke and impact of depression on stroke outcome: an updated systematic review of observational studies. International Journal of Stroke 2014;9:1026-1036

Hackett ML, Köhler S, O’Brien JT, Mead GE. Neuropsychiatric outcomes of stroke. Lancet Neurology 2014;13:525-534

Hackett ML, Carter G, Crimmins D, Clarke T, Arblaster L, Billot L, Mysore J, Sturm J. imProving Outcomes after Stroke: results from the randomised clinical pilot trial. International Journal of Stroke 2013; 8:707-710

Research

Clinical Trials

  • AFFINITY: An Australasian, multi-centre, randomized, double-blind, placebo-controlled trial of the efficacy of fluoxetine in improving functional recovery after acute stroke
  • FOCUS (UK), EFFECTS (Sweden): sister trials to AFFINITY
  • HeadPoST:Head Position in Stroke Trial (HeadPoST)
  • ATTEND:Family-Led Rehabilitation after Stroke in India
  • TEXT-ME:Tobacco, exercise and diet messages trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease

Observational / Cohort Studies

  • Getting it right:The validation of a culturally-specific measure to identify depression in Aboriginal and Torres Strait Islander people with or without chronic disease
  • SEISMIC:Sydney Epilepsy Study to Measure Illness Consequences
  • POISE:Psychosocial disability and return to work in younger stroke survivors

Cochrane Systematic Reviews and Meta-Analyses

Cochrane systematic reviews and meta-analyses

  • Treatment for depression after stroke
  • Prevention of depression after stroke
  • Pharmaceutical interventions for emotionalism after stroke

Selective serotonin reuptake inhibitors for stroke recovery